Back to results
US 2026/0199231 A1Published application
Fluticasone and vilanterol formulation and inhaler
AssigneeKindeva Drug Delivery L.P.
InventorsSarah J. Dexter, Philip M. Cocks
Life of this patent
Estimating the term…
Abstract
A composition comprising particulate fluticasone or a pharmaceutically acceptable salt or solvate thereof, particulate vilanterol or a pharmaceutically acceptable salt or solvate thereof, and 1,1-difluoroethane.
Claims14
1-23. (canceled)
An inhaler comprising:
- a canister;
- a valve disposed on the canister;
- and
- a composition contained in the canister, the composition comprising:
- an active medicament comprising:
- particulate fluticasone or a pharmaceutically acceptable salt or solvate thereof having a canister size between 2 micrometers and 4 micrometers and an ex-actuator size between 2 micrometers and 4 micrometers;
- and
- particulate vilanterol or a pharmaceutically acceptable salt or solvate thereof having a canister size between 1 micrometer and 3 micrometers and an ex-actuator size between 1 micrometer and 3 micrometers;
- and
- a propellant,
- wherein the particulate fluticasone or a pharmaceutically acceptable salt or solvate thereof and the particulate vilanterol or a pharmaceutically acceptable salt or solvate thereof are suspended in the propellant.
8 more elements
Dependencies are inferred from the claim text.